View Drug - Pancreapar
Jump to: Basic Info Purpose Indications Warnings Reactions

Pancreapar

Generic: SYZYGIUM JAMBOLANUM, GLANDULA SUPRARENALIS SUIS, HYDRASTIS CANADENSIS, HYPOPHYSIS SUIS, PANCREAS SUIS, PHASEOLUS, ACETICUM ACIDUM, LACTICUM ACIDUM, PHOSPHORICUM ACIDUM, PHOSPHORUS, URANIUM NITRICUM

100%
Basic Information
Manufacturer
Energique, Inc.
Product Type
HUMAN OTC DRUG
Route of Administration
ORAL
FDA Set ID
ba9c13d0-92de-4159-8a35-215e3de50c07
Purpose
INDICATIONS: May temporarily relieve thirst, weakness and feebleness with weight loss, frequent urination, and weakness and fatigue with lethargy.

**Claims based on traditional homeopathic practice, not accepted medical evidence.

Not FDA evaluated.
Indications & Usage
INDICATIONS: May temporarily relieve thirst, weakness and feebleness with weight loss, frequent urination, and weakness and fatigue with lethargy.

**Claims based on traditional homeopathic practice, not accepted medical evidence.

Not FDA evaluated.
Warnings
WARNINGS: If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away.

Do not use if tamper evident seal is broken or missing.

Store in a cool, dry place.